Common heart medication may slow cognitive decline in Alzheimer’s
A Swedish registry of 7,308 patients links newer blood thinners to slower cognitive decline in people who also…
New drug for chronic hives registered in Hong Kong
Patients suffering from chronic hives can enjoy more treatment options, as a new drug targeting the disease has…
Researcher Christopher McCurdy Did Not Disclose Kratom Conflicts of Interest — ProPublica
The leading scientist urging policymakers not to criminalize kratom, a substance that has left a trail of death…
Paxlovid, long Covid, weed, Trump drug deals: Morning Rounds
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.…
Walmart to Pay $50 Million Over Opioid Prescription Case
(Gray News) – Walmart has agreed to pay $50 million to the federal government to resolve allegations that…
MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balance
The Medicines and Healthcare products Regulatory Agency (MHRA) has completed its review of Avacopan Vifor (previously known as…
Experimental weight loss jab outperforms Mounjaro in latest study
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Lenacapavir shot offers hope, but access is constrained
Lindiwe Mqatazana is not taking any chances with her health, or with that of her unborn child. “There…
Mayo-founded anaphylaxis kits will accommodate new nasal spray
With the Nasal Adrenaline spray becoming available today in Ireland, a Mayo man who created an ‘Emergency…
Walmart to Pay $50 Million Over Opioid Prescription Case
(Gray News) – Walmart has agreed to pay $50 million to the federal government to resolve allegations that…
New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
At Week 52, Taltz and Zepbound maintained or further improved psoriasis or psoriatic arthritis disease activity from Week…
Walmart to Pay $50 Million Over Opioid Prescription Case
(Gray News) – Walmart has agreed to pay $50 million to the federal government to resolve allegations that…